Olivier Riou

Montpellier, 34090, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy.

Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy.

Journal: Cancers

Published: March 31, 2026

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 13, 2025

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.

Journal: Biomedicines

Published: July 18, 2025

Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry study.

Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 29, 2025

Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.

Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 17, 2025

Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial.

Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 15, 2025

Radiotherapy for liver tumours⭑.

Radiotherapy for liver tumours⭑.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 07, 2025

Tumour and normal tissue radiosensitivity: 2025 update.

Tumour and normal tissue radiosensitivity: 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: February 27, 2025

Role of radiotherapy in the management of bladder cancer: Recommendations of the Société française de radiothérapie oncologique, 2025 update.

Role of radiotherapy in the management of bladder cancer: Recommendations of the Société française de radiothérapie oncologique, 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: January 31, 2025

Radiotherapy of pancreatic cancers: 2025 update.

Radiotherapy of pancreatic cancers: 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: January 26, 2025

Development of Multiparametric Prognostic Models for Stereotactic Magnetic Resonance Guided Radiation Therapy of Pancreatic Cancers.

Development of Multiparametric Prognostic Models for Stereotactic Magnetic Resonance Guided Radiation Therapy of Pancreatic Cancers.

Journal: International journal of radiation oncology, biology, physics

Published: December 20, 2024

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Journal: International journal of cancer

Published: December 05, 2024

Showing 1-12 of 84

Last Updated: 09/26/2026